Loading insider details...
Latest Form 4 (Aug 6, 2026): Sale of 1,142 ACRV shares, $1.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 6, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Sale | 1,142 | $1.8K |
| May 20, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 46,167 | n/a |
| Mar 3, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 132,925 | n/a |
| Jan 16, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Purchase | 8,832 | $15.0K |
| Aug 5, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 1,164 | $1.5K |
| Apr 3, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 35,209 | n/a |